Financial and Trade Notices




NEW ZEALAND GAZETTE, No. 35 — 30 MARCH 2017

2017-go1515

Approval of Qualified Persons for the Purposes of Section 36(1)(d)(ii) of the Financial Reporting Act 2013

I am satisfied that the individuals named below satisfy the requirements prescribed for the purposes of section 36A(2)(a) of the Financial Reporting Act 2013 and, pursuant to section 36(1)(d)(ii) of that Act, I approve:

Barnikel, Yvonne Louise, of Sydney, Australia, ASIC Registered Auditor No. 493716 and a member of Chartered Accountants Australia and New Zealand

Brown, Alison Margaret, of Melbourne, Australia, ASIC Registered Auditor No. 295571 and a member of Chartered Accountants Australia and New Zealand

Haynes, David Malcolm, of Sydney, Australia, ASIC Registered Auditor No. 490090 and a member of Chartered Accountants Australia and New Zealand

Hume, Cameron John, of Sydney, Australia, ASIC Registered Auditor No. 295720 and a member of Chartered Accountants Australia and New Zealand

Karekinian, James Sarkis, of Sydney, Australia, ASIC Registered Auditor No. 488970 and a member of Chartered Accountants Australia and New Zealand

Sherwood, Gary Neil, of Sydney, Australia, ASIC Registered Auditor No. 340221 and a member of Chartered Accountants Australia and New Zealand

Talbot, David Graham, of Sydney, Australia, ASIC Registered Auditor No. 439789 and a member of Chartered Accountants Australia and New Zealand

Zahra, Anthony John, of Sydney, Australia, ASIC Registered Auditor No. 424899 and a member of Chartered Accountants Australia and New Zealand

for the time being for the purposes of that section.

Dated at Wellington this 30th day of March 2017.

YESH AMIN, Assistant Registrar of Companies.

2017-go1522

Notice of Application to Register a Trade Name Product (Notice No. MPI 734)

Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: VANGUARD® CC 3 Intranasal

Reference: A011428

Active Ingredients and Concentrations:
Bordetella bronchiseptica, canine adenovirus type 2 and parainfluenza vaccine

Formulation Type: Aqueous solution or suspension (on reconstitution)

General Use Claim:
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing respiratory disease caused by canine adenovirus type 2 (CAV-2) virus, canine parainfluenza caused by canine parainfluenza (CPI) virus, and disease caused by Bordetella bronchiseptica.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

a. must state in full the reasons for making the submission;

b. may state any decision sought on that application; and

c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

51



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 35





✨ LLM interpretation of page content

💰 Approval of Qualified Persons for Financial Reporting Act 2013

💰 Finance & Revenue
30 March 2017
Financial Reporting Act 2013, Qualified Persons, ASIC Registered Auditors, Chartered Accountants Australia and New Zealand
8 names identified
  • Yvonne Louise Barnikel, Approved Qualified Person
  • Alison Margaret Brown, Approved Qualified Person
  • David Malcolm Haynes, Approved Qualified Person
  • Cameron John Hume, Approved Qualified Person
  • James Sarkis Karekinian, Approved Qualified Person
  • Gary Neil Sherwood, Approved Qualified Person
  • David Graham Talbot, Approved Qualified Person
  • Anthony John Zahra, Approved Qualified Person

  • Yesh Amin, Assistant Registrar of Companies

🌾 Notice of Application to Register a Trade Name Product

🌾 Primary Industries & Resources
Trade Name Product, VANGUARD® CC 3 Intranasal, Agricultural Compounds and Veterinary Medicines Act 1997, MPI, Vaccine
  • Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries